Transfusion-related immunosuppression

References 

1. Hébert PC, Wells G, Blajchman MA, et al. A multicentre, randomised, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409–417
   • MEDLINE
   • CrossRef
2. Opelz G, Sengar DP, Mickey MR, et al. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973;5:253–259
   • MEDLINE
3. Adamson JW. New blood, old blood or no blood?. N Engl J Med. 2008;12:1295
4. Van de Watering LMG, Hermans J, Hobiers JGA, et al. Beneficial effect of leucocyte depletion of transfused blood on post-operative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 1998;97:562–568
   • MEDLINE
5. Gantt CL. Red blood cells for cancer patients. Lancet. 1981;2:363
   • MEDLINE
6. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007;21:327–348
   • Abstract
   • Full Text
   • Full-Text PDF (294 KB)
   • CrossRef
7. Vamvakas EC. Transfusion-associated cancer recurrence and infection: meta-analysis of the randomized controlled clinical trials. Transfusion. 1996;36:175–186
8. Blajchman MA. Transfusion immunomodulation or TRIM: what does it mean clinically?. Haematology. 2005;10(Suppl. 1):208–214
   • CrossRef
9. Blajchman MA. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse?. Transfusion. 1999;39:665–670
10. Vamvakas EC. White-blood-cell containing allogenic blood transfusion, postoperative infection, and mortality: a meta-analysis of observational, ‘before-and-after’ studies. Vox Sang. 2004;86:111–119
    • MEDLINE
    • CrossRef